IP Library Granted Patent US 7,015,321
Granted Patent B2
US 7,015,321 · App. 10/685,658 · Granted Mar 21, 2006

Synthesis of non-symmetrical sulfamides using burgess-type reagents

Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,015,321
App. No.
10/685,658
Granted
Mar 21, 2006
Kind
B2
Abstract

A practical and high-yielding method for the efficient, one-step synthesis of diverse classes of N,N′-differentiated sulfamides employs a wide range of amino alcohols and simple amines using Burgess-type reagents. This methodology extends the application and availability of sulfamides within the fields of chemical biology, medicinal chemistry, asymmetric synthesis, and supramolecular chemistry.

Claims (32)

1. A process for the synthesizing a mono-protected, non-symmetrical cyclic sulfamide III from an amino alcohol I and Burgess reagent II represented by the following structures:

the process comprising the following steps:

Step A: contacting a solution of the amino alcohol I in a non-reactive solvent with a quantity of the Burgess reagent II for producing sulfamide III; then, after consuming amino alcohol I

Step B: neutralizing the reaction of said Step A by dilution with a non-reactive solvent and treatment with an aqueous solution; and then

Step C: isolating sulfamide III;

wherein:

X is absent or is a diradical selected from the group consisting of the following structures:

R 1 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or is a diradical forming a ring with R 2 ;

R 2 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or is a diradical forming a ring with R 1 or R 3 or R 4 , or is a diradical forming a part of an aromatic ring with R 5 ;

R 3 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or is a diradical forming a ring with R 1 or R 2 or R 5 or is a diradical forming half of a π-bond with R 6 ;

R 4 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, and benzyl or is a diradical forming a ring with R 2 or with R 5 ;

R 5 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or is a diradical forming a ring with R 1 or R 2 or R 6 or is a diradical forming part of an aromatic ring with R 3 ;

R 6 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or is a diradical forming a ring with R 1 or R 2 or R 5 or is a diradical forming half of a π-bond as part of an aromatic ring with R 3 ;

R 7 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl;

Y is a radical selected from the group consisting of —CH 3 , —CH 2 Ph and —CH 2 CH═CH 2 ;

with the following proviso:

if R 2 and R 5 are part of an aromatic ring; then R 3 and R 6 make up a full π-bond;

if X is absent, then R 3 cannot be half of a π-bond and R 2 is not part of an aromatic ring.

2. A process according to claim 1 where the quantity of Burgess reagent II is 2.5 equivalents.

3. A process according to claim 2 where X is absent.

4. A process according to claim 2 where X is a diradical with the following structure:

5. A process according to claim 2 where X is a diradical with the following structure:

6. A process for synthesizing a mono-protected, non-symmetrical sulfamide V from an amine IV and Burgess reagent II represented by the following structures:

the process comprising the following steps:

Step A: contacting a solution of the amine IV with a quantity of Burgess reagent II for producing sulfamide V; then

Step B: neutralizing the reaction of said Step A by dilution with a non-reactive solvent and treatment with an aqueous solution; and then

Step C: isolating the sulfamide V;

wherein:

R 1 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or a diradical forming a ring with R 2 ;

R 2 is a radical selected from the group consisting of hydrogen, C 1 –C 6 alkyl, aryl, heteroaryl, alkylaryl, and benzyl, or a diradical forming a ring with R 1 ; and

Y is a radical selected from the group consisting of —CH 3 , —CH 2 Ph and —CH 2 CH═CH 2 .

7. A process according to claim 6 wherein the quantity of Burgess reagent II is 1.25 equivalents.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 13, 2017
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044858/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2004
From: NICOLAOU, KYRIACOS C.; LONGBOTTOM, DEBORAH; SNYDER, SCOTT A.; HUANG, XIANHAI
To: SCRIPPS RESEARCH INSTITUTE, THE
Reel/Frame 015043/0955 →
Continuity (2)
Provisional Application 6041793600 · Oct 12, 2002
Related Publication 20040138448A1 · Jul 15, 2004